ABION
Advancing companion diagnostic-based medicine as innovators across global markets.
ABION
Industry:
Health Care Medical Pharmaceutical
Founded:
2007-04-16
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.abionbio.com
Total Employee:
11+
Status:
Active
Contact:
02 – 6006 – 7657
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Apache Wordpress Plugins Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
TaiGen Biotechnology
TaiGen is a pharmaceutical company discovering, developing and commercializing drugs to treat cancers, infectious diseases and diabetics.
Current Employees Featured
Official Site Inspections
http://www.abionbio.com Semrush global rank: 5.67 M Semrush visits lastest month: 1.49 K
- Host name: 115.68.168.189
- IP address: 115.68.168.189
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Abion"
Company – ABION BIO
On behalf of our entire team, I extend my heartfelt gratitude to all of you who are always committed and supportive of what we do at ABION. With an endless dedication to R&D, ABION is moving forward with the mission to find and …See details»
ABION BIO
이메일 [email protected] / 전화 02–6006–7657. Close Menu. COMPANY. 에이비온 소개 ...See details»
Abion - Crunchbase Company Profile & Funding
Organization. Abion . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 02 …See details»
ABION BIO
6 days ago In the field of oncology, ABION is developing ABN401, a targeted c-Met inhibitor for non-small cell lung cancer (NSCLC), and ABN501, a Pan-Carcinoma Claudin-3 antibody, as therapeutic options in various of cancers.See details»
Abion Inc. - LinkedIn
Abion will participate in the 2024 CBD S&T Conference, held in Florida, USA, from December 2-5. ABN101 is a therapeutic inhalation agent designed to inhibit viral replication in CBRN …See details»
Abion - Products, Competitors, Financials, Employees, …
Abionbio.com. Overview & Products; Financials; Founded Year 2007. Stage IPO | IPO. Total Raised $8.92M. Date of IPO 7/14/2014. About Abion. Abion is a biopharmaceutical company …See details»
Abion Inc. Company Profile - South Korea - EMIS
Jul 5, 2024 The Company is a Korea-based company principally engaged in the research, development and sales of pharmaceuticals. Along with its subsidiaries, the Company operates …See details»
ABION Inc. (KOSDAQ: 203400) - Stock Analysis
Dec 9, 2024 ABION Inc. operates as a pharmaceutical biotech Company in South Korea and internationally. The company develops anticancer therapeutic drugs, such as ABN401, a …See details»
Abion Company Profile - Office Locations, Competitors, Revenue
Abion (formerly Reference Biolab) is a company that develops therapeutics for unmet medical needs in oncology, CNS, and infectious diseases. It provides chemical and biological drugs …See details»
Abion | VentureRadar
Abion is committed to developing innovative medicines including chemical and biological drugs and vaccines as part of our nationwide research... ... Find out more ...See details»
Company – ABION BIO
이메일 [email protected] / 전화 02–6006–7657. Close Menu. COMPANY. 에이비온 소개 ...See details»
Abion - Overview, News & Similar companies | ZoomInfo.com
Oct 13, 2023 Who is Abion. Abion was established as a biotech venture at Seoul National University in 2007. Since its foundation, the company has continued to make progress i n …See details»
Company Abion Inc. - MarketScreener.com
Dec 30, 2014 ABION Inc. is a Korea-based company principally engaged in the research, development and sales of pharmaceuticals. Along with its subsidiaries, the Company operates …See details»
Abion Inc. - ASCO Annual 2024
Jun 3, 2024 ABION, based in South Korea, develops innovative Best-In-Class and First-In-Class lung cancer drugs. Our lead program, Vabametkib, a selective TKI for MET NSCLC in Phase 2 …See details»
Abion Inc. Information - RocketReach
Abionbio.com; View Similar People. Related Companies Ahn-Gook Pharmaceutical Co Ltd. 18 $161.6m DNA Link. 39 $15.3m Dongwha Pharm Co Ltd. 37 $237.2m Daewon Pharmaceutical …See details»
Company Information - RocketReach
Abionbio.com; Nirmal Rajasekaran Project Lead at Abion Inc. Seoul, South Korea View. 1 abionbio.com; View Similar People. Related Companies Ahn-Gook Pharmaceutical Co Ltd. 18 …See details»
Abion - Company Profile - Tracxn
Oct 11, 2024 Abion ranks 192nd among 610 active competitors. 229 of its competitors are funded while 149 have exited. Overall, Abion and its competitors have raised over $20.7B in …See details»
history – ABION BIO
Joined by a strategic investor “Labgenomics” for the development of anti-cancer drugSee details»
ABION, Inc. (ABION, Inc.) - 药物管线_专利_临床试验_投融营收_最 …
了解ABION, Inc. (ABION, Inc.)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验, 3篇新闻和23篇文献，疾病领域:肿瘤，神经系统疾病，免疫系统疾病，内分泌与代谢疾病，技术 …See details»
Abion will participate in JPM-Related ‘Biotech Showcase’ and ‘Bio ...
6 days ago “Partnering with global pharmaceutical and biotech companies offers an opportunity to build new networks” Abion, an innovative pharmaceutical development company, …See details»